covering multiple aspects of NDD (neurodevelopmental Disorders)
diagnostic and care of a large number of infants at risk to develop a NDD or with a NDD
combining clinical and preclinical data
The aim of I2-D2 is to define individual trajectories of the NDD patients to early identify, in each child, the key factors responsible for the abnormal brain development, to develop predictive biomarkers, and ultimately individualized therapies.
The Excellence Center InovAND is designed to promote excellence in research and to foster the transfer of innovative discoveries to improve the understanding, prevention, diagnosis, treatment and care of people with neurodevelopmental disorders.
In 2019, the hospital hosted the creation of the FHU I2-D2 and the Autism and Neurodevelopmental Disorders Excellence Center InovAND, bringing together more than 30 clinical and scientific teams in a network designed to promote excellence in research.
Our aim is therefore to promote excellence and synergy among researchers and clinicians, within a single location – the Child Brain Institute – to accelerate the pace of scientific discoveries and, ultimately, to improve the cognitive and emotional development of children.
Postes d’accueil pour Assistants Hospitalo-Universitaires (AHU), Chefs de Clinique Assistants (CCA), Praticiens Contractuels (PC) et Praticiens Hospitaliers (PH) Date limite de soumission du dossier : lundi 20 mars…
9 mars 2023 – de 11h30 à 12h30 A l’occasion de ce 2e webinaire, Morgane Bureau (membre du Point de Contact National Horizon Europe MSCA) et Paul Olivier…
3RD ESCAP RESIDENTIAL SCHOOL ON ASSESSMENT AND TREATMENT OF PSYCHIATRIC DISORDERS IN CHILDREN AND ADOLESCENTS September 27th to 30th, 2023 Sicily, Italy The course is addressed to: 1) Residents (trainees)…
